<SEC-DOCUMENT>0001486189-23-000008.txt : 20230621
<SEC-HEADER>0001486189-23-000008.hdr.sgml : 20230621
<ACCEPTANCE-DATETIME>20230621164929
ACCESSION NUMBER:		0001486189-23-000008
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230619
FILED AS OF DATE:		20230621
DATE AS OF CHANGE:		20230621

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Levy Oded
		CENTRAL INDEX KEY:			0001950696

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41097
		FILM NUMBER:		231030535

	MAIL ADDRESS:	
		STREET 1:		C/O CARDIO DIAGNOSTICS HOLDINGS INC.
		STREET 2:		400 N. ABERDEEN ST., SUITE 900
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60642

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cardio Diagnostics Holdings, Inc.
		CENTRAL INDEX KEY:			0001870144
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870925574
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		400 N ABERDEEN ST, SUITE 900
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60642
		BUSINESS PHONE:		855-226-9991

	MAIL ADDRESS:	
		STREET 1:		400 N ABERDEEN ST, SUITE 900
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60642

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mana Capital Acquisition Corp.
		DATE OF NAME CHANGE:	20210629
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0407</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2023-06-19</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001870144</issuerCik>
        <issuerName>Cardio Diagnostics Holdings, Inc.</issuerName>
        <issuerTradingSymbol>CDIO</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001950696</rptOwnerCik>
            <rptOwnerName>Levy Oded</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CARDIO DIAGNOSTICS HOLDINGS INC.</rptOwnerStreet1>
            <rptOwnerStreet2>400 N. ABERDEEN ST., SUITE 900</rptOwnerStreet2>
            <rptOwnerCity>CHICAGO</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60642</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2023-06-19</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionTotalValue>
                    <value>50000</value>
                    <footnoteId id="F2"/>
                </transactionTotalValue>
                <transactionPricePerShare>
                    <value>0</value>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2023-06-30</value>
            </exerciseDate>
            <expirationDate>
                <value>2023-12-31</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityValue>
                    <value>50000</value>
                </underlyingSecurityValue>
            </underlyingSecurity>
            <postTransactionAmounts>
                <valueOwnedFollowingTransaction>
                    <value>50000</value>
                    <footnoteId id="F2"/>
                </valueOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.</footnote>
        <footnote id="F2">Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023, (ii) $12,500 in value on September 30, 2023, and (iii) $12,500 in value on December 31, 2023.</footnote>
        <footnote id="F3">The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Elisa Luqman as attorney-in-fact for Oded Levy</signatureName>
        <signatureDate>2023-06-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
